These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10022286)

  • 21. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intermittent PTH administration in the periodontitis-associated bone loss in ovariectomized rats.
    Marques MR; da Silva MA; Manzi FR; Cesar-Neto JB; Nociti FH; Barros SP
    Arch Oral Biol; 2005 Apr; 50(4):421-9. PubMed ID: 15748695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone.
    Bradbeer JN; Arlot ME; Meunier PJ; Reeve J
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):282-9. PubMed ID: 1424211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
    Shen V; Birchman R; Liang XG; Wu DD; Dempster DW; Lindsay R
    J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.
    Yang Y; Aghazadeh-Habashi A; Panahifar A; Wu Y; Bhandari KH; Doschak MR
    Drug Deliv Transl Res; 2017 Aug; 7(4):482-496. PubMed ID: 28721611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclization by a specific lactam increases the ability of human parathyroid hormone (hPTH)-(1-31)NH2 to stimulate bone growth in ovariectomized rats.
    Whitfield JF; Morley P; Willick G; Langille R; Ross V; MacLean S; Barbier JR
    J Bone Miner Res; 1997 Aug; 12(8):1246-52. PubMed ID: 9258755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model.
    Lane NE; Kimmel DB; Nilsson MH; Cohen FE; Newton S; Nissenson RA; Strewler GJ
    J Bone Miner Res; 1996 May; 11(5):614-25. PubMed ID: 9157776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
    J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.
    Chunxiao W; Jingjing L; Yire X; Min D; Zhaohui W; Gaofu Q; Xiangchun S; Xuejun W; Jie W; Taiming L
    Regul Pept; 2007 Jun; 141(1-3):35-43. PubMed ID: 17300845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological effects of a recombinant hPTH(1-34) derived peptide on ovariectomized rats.
    Chunxiao W; Chengying G; Liang J; Xiaoming S; Feng G; Junting Y; Wenhui W; Yu W; Jingjing L
    Eur J Pharmacol; 2017 Jan; 794():193-200. PubMed ID: 27887949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats.
    Shen V; Birchman R; Xu R; Otter M; Wu D; Lindsay R; Dempster DW
    J Clin Invest; 1995 Nov; 96(5):2331-8. PubMed ID: 7593620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.
    Mosekilde L; Danielsen CC; Gasser J
    Endocrinology; 1994 May; 134(5):2126-34. PubMed ID: 8156913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: a microarchitectural and mechanical study.
    Yang X; Chan YH; Muthukumaran P; Dasde S; Teoh SH; Lee T
    Bone; 2011 May; 48(5):1154-63. PubMed ID: 21334474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.
    Ma YF; Jee WS; Ke HZ; Lin BY; Liang XG; Li M; Yamamoto N
    J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parathyroid hormone in the treatment of osteoporosis.
    Fujita T
    BioDrugs; 2001; 15(11):721-8. PubMed ID: 11707147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human parathyroid hormone (1-34) increases mass and structure of the cortical shell, with resultant increase in lumbar bone strength, in ovariectomized rats.
    Arita S; Ikeda S; Sakai A; Okimoto N; Akahoshi S; Nagashima M; Nishida A; Ito M; Nakamura T
    J Bone Miner Metab; 2004; 22(6):530-40. PubMed ID: 15490262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.